In line with the upregulation of the TGF-β pathway genes observed in these F-MPN samples, we noted an enrichment of SMAD3, RUNX2, and SP5 TF motifs (Figure 2E). The gene discussed is RUNX2; the disease is myeloproliferative disorder.